ヘルスケア市場における5G

出版:MarketsandMarkets

5G in Healthcare Market by Component (Hardware, Connectivity, Services) Application (Remote Patient Monitoring, Connected Medical Devices, AR/VR, Connected Ambulance, Asset Tracking) End User (Healthcare Providers, Payers) – Global Forecast to 2026

出版 MarketsandMarkets
出版年月 2021年10月
ページ数 208
図表数 151
種別 英文調査報告書

レポート目次  お問合せ

ヘルスケア市場における5G コンポーネント(ハードウェア、接続性、サービス)、用途(遠隔患者モニタリング、コネクテッド医療機器、AR / VR、コネクテッド救急車、資産追跡)エンドユーザー(医療提供者、支払者)別

5G stands for the fifth generation of mobile communication technology. With each generation’s new technology and standards, there have been improvements in transmission speed and network capacity. 5G represents a big leap in cellular technology and in healthcare by providing essential levels of connectivity to enable a new health ecosystem, one that can meet the needs of patients and providers accurately, efficiently, cost-effectively, conveniently, and at a substantial scale. This massive network will include billions of low-bitrates and low-energy connected health monitoring devices, remote sensors, and clinical wearables, with 5G providing a backbone infrastructure for IoT.

The 5G in healthcare market is valued at an estimated USD 215 million in 2021 and is projected to reach USD 3,667 million by 2026, at a CAGR of 76.3% during the forecast period. The increasing adoption of telehealth and robotics surgery due to COVID-19 and the rising adoption of 5G-enabled wearable medical devices for real-time remote patient monitoring are key factors driving the growth of this market. The ability of 5G technology to transmit large patient data files quickly, advancements in telecommunication, and the availability of low-cost sensors are other major factors that are driving the growth of this market. However, the high cost of deployment of the 5G network is expected to restrain the growth of this market.

“The Hardware segment accounted for the largest market share in 2020.”
Based on component, the 5G in healthcare market is segmented into hardware, services, and connectivity. The hardware segment accounted for the largest share of the 5G in healthcare market in 2020. This segment is projected to reach USD 1,871.7 million by 2026, at a CAGR of 76.0% during the forecast period. The large share of this segment can primarily be attributed to the need for frequent upgradation or replacement to make optimal use of the latest software available in the market.
“The Connected Medical Devices segment accounted for the largest market share in 2020.”

Based on application, the 5G in healthcare market is segmented into remote patient monitoring, connected ambulance, connected medical devices, asset tracking for medical devices, and AR/VR. The connected medical devices segment accounted for the largest share of the 5G in healthcare market in 2020. This application segment is projected to reach USD 1,405.3 million by 2026 from USD 94.5 million in 2021, at a CAGR of 71.6% during the forecast period. The large share of this segment can be attributed to the growth in the telehealth market and the growing inclination towards home healthcare. The high burden of COVID-19, increasing healthcare costs, strong government support and initiatives, and the growing focus on the quality of care and patient safety are further driving the market for connected medical devices in the 5G in healthcare market.

“The Healthcare Providers segment accounted for the largest market share in 2020.”
Based on end users, the 5G in healthcare market is segmented into healthcare providers, healthcare payers, and other end users. The healthcare providers segment accounted for the largest share of the 5G in healthcare market in 2020. This end-user segment is projected to reach USD 3,011.1 million by 2026 from USD 170.4 million in 2021, at a CAGR of 77.6% during the forecast period. The large share of this segment can be attributed to the rising need for an efficient healthcare system, growing patient volume, increasing number of hospitals and ambulatory care centers, growth in telehealth, rising adoption of 5G-enabled wearable medical devices, and the rising demand for better technologies that help in the easy transfer of large data files.

“Asia Pacific was the largest regional market for 5G in healthcare market in 2020“

The global 5G in healthcare market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, Asia Pacific accounted for the largest share of 33.8% of the global market. The APAC is the largest and fastest-growing region in the 5G in healthcare market. This growth can be attributed to the significant adoption of advanced technologies, increasing number of IoT-enabled medical devices, continuously enhancing network connectivity, and government initiatives for IoT.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation – C-level: 25%, Director-level: 55%, and Others: 20%
• By Region – North America: 40%, Europe: 25%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 5%

The prominent players in the 5G in healthcare market are AT&T (US), Verizon (US), China Mobile Limited (China), Qualcomm (US), T-Mobile (US), Ericsson (Sweden), Telit (Poland), Telus (Canada), Vodafone (UK), Nokia (Finland), Samsung (South Korea), Deutsche Telekom AG (Germany), Orange S.A. (France), SK Telecom Co., Ltd. (South Korea), BT Group (UK), NTT DOCOMO (UK), NEC Corporation (Japan), Telefónica (Spain), Airtel (India), Huawei Technologies Co., Ltd. (China), and Cisco (US). These companies adopted strategies such as service launches, business expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their presence in the 5G in healthcare market.

Research Coverage:
The report analyzes the 5G in healthcare market and aims at estimating the market size and future growth potential of various market segments, based on by component, application, end user and region.
The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
 Market Penetration: Comprehensive information on the product portfolios of the top players in the 5G in healthcare market. The report analyzes this market by type of component, application, end user and region.
 Market Development: Comprehensive information on the lucrative emerging markets, by type of component, application, end user and region.
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the 5G in healthcare market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the 5G in healthcare market.


目次

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 26
1.2.2 MARKETS COVERED 26
1.2.3 YEARS CONSIDERED FOR THE STUDY 27
1.3 CURRENCY 27
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 27
1.4 LIMITATIONS 28
1.5 STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 1 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 32
FIGURE 2 PRIMARY SOURCES 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Insights from primary experts 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION: 5G IN HEALTHCARE MARKET 36
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE FROM 5G IOT VENDORS 37
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY (DEMAND SIDE): DEMAND-SIDE MARKET ESTIMATIONS THROUGH APPLICATION/USE CASES 39
FIGURE 8 CAGR PROJECTIONS: OVERALL 5G IN HEALTHCARE MARKET 39
2.2.1 TOP-DOWN APPROACH 40
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41
FIGURE 9 DATA TRIANGULATION METHODOLOGY 41
2.4 MARKET RANKING ANALYSIS 42
2.5 ASSUMPTIONS FOR THE STUDY 42
2.6 RISK ASSESSMENT 43
TABLE 2 RISK ASSESSMENT: 5G IN HEALTHCARE MARKET 43
2.7 LIMITATIONS 43

3 EXECUTIVE SUMMARY 44
FIGURE 10 5G IN HEALTHCARE MARKET, BY COMPONENT,
2021 VS. 2026 (USD MILLION) 44
FIGURE 11 5G IN HEALTHCARE MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 45
FIGURE 12 5G IN HEALTHCARE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 45
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE 5G IN HEALTHCARE MARKET 46
4 PREMIUM INSIGHTS 47
4.1 5G IN HEALTHCARE MARKET OVERVIEW 47
FIGURE 14 RISING ADOPTION OF 5G-ENABLED WEARABLE MEDICAL DEVICES FOR REAL-TIME REMOTE PATIENT MONITORING TO DRIVE MARKET GROWTH 47
4.2 ASIA PACIFIC: 5G IN HEALTHCARE MARKET, BY END USER AND COUNTRY (2020) 48
FIGURE 15 HEALTHCARE PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 48
4.3 5G IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
FIGURE 16 JAPAN TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 49
4.4 REGIONAL MIX: 5G IN HEALTHCARE MARKET (2019−2026) 50
FIGURE 17 ASIA PACIFIC WILL DOMINATE THE 5G IN HEALTHCARE MARKET DURING THE FORECAST PERIOD 50
4.5 5G IN HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING MARKETS 50
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES:
IMPACT ANALYSIS 51
5.2.1 DRIVERS 52
5.2.1.1 Increasing adoption of telehealth and robotics surgery
due to COVID-19 52
5.2.1.2 Rising adoption of 5G-enabled wearable medical devices for real-time remote patient monitoring 53
FIGURE 19 SMARTPHONE USERS AND PENETRATION WORLDWIDE, 2016–2021 53
5.2.1.3 Ability of 5G technology to transmit large patient data files quickly 53
5.2.1.4 Advancements in telecommunication 54
5.2.1.5 Availability of low-cost sensors 54
5.2.2 RESTRAINTS 54
5.2.2.1 High cost of deployment of the 5G network 54
5.2.3 OPPORTUNITIES 55
5.2.3.1 Role of AI in 5G healthcare 55
5.2.3.2 High reliability and low latency 5G networks to accelerate a new wave of healthcare applications 55
5.2.4 CHALLENGES 56
5.2.4.1 Delay in spectrum harmonization across geographies 56
5.2.4.2 Data breach and security concerns 56
FIGURE 20 US: NUMBER OF DATA BREACHES (2005–2020) 57
6 INDUSTRY INSIGHTS 58
6.1 INTRODUCTION 58
6.2 INDUSTRY TRENDS 58
6.2.1 RISING DEMAND FOR 5G TECHNOLOGY ACROSS
THE HEALTHCARE CONTINUUM 58
FIGURE 21 TELECOM OPERATOR REVENUE POTENTIAL IN ADDRESSING HEALTHCARE INDUSTRY DIGITALIZATION WITH 5G IN 2026 58
6.2.2 5G-ENABLED INTERNET OF MEDICAL THINGS (IMOT) 59
FIGURE 22 5G HEALTHCARE USE CASES 60
6.2.3 5G-ENABLED HEALTHCARE TRAINING AND THERAPEUTIC & REHABILITATIVE USES FOR AR/VR 60
6.2.4 PRIVATE 5G NETWORKS 61
6.3 TECHNOLOGY ANALYSIS 62
6.3.1 INTRODUCTION 62
FIGURE 23 COMPARISON OF 5G TECHNOLOGY SPECIFICATIONS TO
OTHER WIRELESS PROTOCOLS 62
6.3.2 WI-FI 62
6.3.3 WIMAX 62
6.3.4 NETWORK SLICING IN RADIO ACCESS NETWORK 63
6.3.5 NETWORK SLICING IN CORE NETWORK 63
6.3.6 NETWORK SLICING IN TRANSPORT NETWORK 63
6.3.7 SMALL CELL NETWORKS 63
6.3.8 LONG-TERM EVOLUTION NETWORKS 64
6.3.9 CITIZENS BROADBAND RADIO SERVICES 64
6.3.10 MULTEFIRE 64
6.4 REGULATORY IMPLICATIONS 64
6.4.1 GENERAL DATA PROTECTION REGULATION 64
6.4.2 CALIFORNIA CONSUMER PRIVACY ACT 65
6.4.3 PAYMENT CARD INDUSTRY DATA SECURITY STANDARD 65
6.4.4 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT 65
6.4.5 DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE 65
6.4.6 HEALTH LEVEL SEVEN 65
6.4.7 GRAMM-LEACH-BLILEY ACT 66
6.4.8 SARBANES-OXLEY ACT 66
6.4.9 SOC 2 66
6.4.10 COMMUNICATIONS DECENCY ACT 66
6.4.11 DIGITAL MILLENNIUM COPYRIGHT ACT 66
6.4.12 ANTI-CYBERSQUATTING CONSUMER PROTECTION ACT 66
6.4.13 LANHAM ACT 67
6.5 PRICING ANALYSIS 67
TABLE 4 5G IN HEALTHCARE MARKET: PRICING ANALYSIS 67
6.6 CASE STUDY ANALYSIS 69
6.6.1 CHINA MOBILE LIMITED 69
6.6.2 AT&T 69
6.7 ECOSYSTEM ANALYSIS 69
TABLE 5 5G IN HEALTHCARE MARKET: ECOSYSTEM MAPPING 69
FIGURE 24 5G IN HEALTHCARE MARKET: ECOSYSTEM MARKET MAP 71
6.7.1 5G TELECOM OPERATORS 71
6.7.2 5G MOBILE SENSOR/CHIPSET TECHNOLOGY PROVIDERS 71
6.7.3 5G MOBILE DEVICE MANUFACTURERS 71
6.7.4 END USER/APPLICATION/USE CASES 71
6.8 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 6 PORTER’S FIVE FORCES ANALYSIS 72
6.8.1 INTENSITY OF COMPETITIVE RIVALRY 73
6.9 COVID-19 IMPACT ON THE 5G IN HEALTHCARE MARKET 74
6.10 PATENT ANALYSIS 75
TABLE 7 PATENTS IN 5G IN HEALTHCARE MARKET 76
FIGURE 25 TOTAL NO. OF PATENTS FILED BY PLAYERS 77
FIGURE 26 FILING TREND 77
7 5G IN HEALTHCARE MARKET, BY COMPONENT 78
7.1 INTRODUCTION 79
TABLE 8 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 79
7.2 HARDWARE 79
7.2.1 HARDWARE IS THE LARGEST COMPONENT SEGMENT OF THE 5G IN HEALTHCARE MARKET 79
TABLE 9 5G IN HEALTHCARE MARKET FOR HARDWARE, BY COUNTRY,
2019–2026 (USD MILLION) 80
7.3 SERVICES 81
7.3.1 SERVICES HELP END USERS EFFECTIVELY DESIGN AND OPERATE NETWORK INFRASTRUCTURE TO GAIN DESIRABLE BUSINESS OUTCOMES 81
7.3.2 PROFESSIONAL SERVICES 81
7.3.3 MANAGED SERVICES 82
TABLE 10 5G IN HEALTHCARE MARKET FOR SERVICES, BY COUNTRY,
2019–2026 (USD MILLION) 82
7.4 CONNECTIVITY 83
7.4.1 5G CONNECTIVITY TO BRING STRONG FOUNDATION FOR INTERNET OF THINGS USE CASES 83
TABLE 11 5G IN HEALTHCARE MARKET FOR CONNECTIVITY, BY COUNTRY,
2019–2026 (USD MILLION) 83

8 5G IN HEALTHCARE MARKET, BY APPLICATION 84
8.1 INTRODUCTION 85
TABLE 12 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 85
8.2 CONNECTED MEDICAL DEVICES 85
8.2.1 CONNECTED MEDICAL DEVICES IS THE LARGEST APPLICATION SEGMENT OF THE 5G IN HEALTHCARE MARKET 85
TABLE 13 5G IN HEALTHCARE MARKET FOR CONNECTED MEDICAL DEVICES,
BY COUNTRY, 2019–2026 (USD MILLION) 86
8.3 REMOTE PATIENT MONITORING 87
8.3.1 PATIENT READMISSION RATE HAS BEEN REDUCING DUE TO THE AVAILABILITY OF PATIENT MONITORING KITS AT HIGH-SPEED 5G CONNECTIVITY 87
TABLE 14 5G IN HEALTHCARE MARKET FOR REMOTE PATIENT MONITORING,
BY COUNTRY, 2019–2026 (USD MILLION) 88
8.4 ASSET TRACKING FOR MEDICAL DEVICES 88
8.4.1 5G IOT ENABLES HEALTHCARE COMPANIES TO DEPLOY EFFICIENT IOT APPLICATIONS, WHICH HELPS THEM TRACK THEIR ASSETS IN REAL-TIME 88
TABLE 15 5G IN HEALTHCARE MARKET FOR ASSET TRACKING FOR MEDICAL DEVICES, BY COUNTRY, 2019–2026 (USD MILLION) 89
8.5 AR/VR 89
8.5.1 5G-POWERED AR AND VR ENABLES HEALTHCARE PROVIDERS TO VISUALIZE PROCEDURES IN AN ENGAGING, LEARNING-BY-DOING PRACTICE THAT WILL ENHANCE THEIR MEDICAL EDUCATION 89
TABLE 16 5G IN HEALTHCARE MARKET FOR AR/VR, BY COUNTRY,
2019–2026 (USD MILLION) 90
8.6 CONNECTED AMBULANCE 90
8.6.1 CONNECTED AMBULANCE IS EMPOWERED BY 5G’S HIGH BANDWIDTH, LOW LATENCY, AND ULTRA-RELIABLE CONNECTIVITY 90
TABLE 17 5G IN HEALTHCARE MARKET FOR CONNECTED AMBULANCE, BY COUNTRY, 2019–2026 (USD MILLION) 91
9 5G IN HEALTHCARE MARKET, BY END USER 92
9.1 INTRODUCTION 93
TABLE 18 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION) 93
9.2 HEALTHCARE PROVIDERS 93
9.2.1 RISING NEED TO IMPROVE THE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST THE USE OF 5G IN HEALTHCARE 93
TABLE 19 5G IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019–2026 (USD MILLION) 94
9.3 HEALTHCARE PAYERS 94
9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO DRIVE THE DEMAND FOR 5G IN HEALTHCARE 94
TABLE 20 5G IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY,
2019–2026 (USD MILLION) 95
9.4 OTHER END USERS 96
TABLE 21 5G IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY,
2019–2026 (USD MILLION) 96
10 5G IN HEALTHCARE MARKET, BY REGION 97
10.1 INTRODUCTION 98
TABLE 22 5G IN HEALTHCARE MARKET, BY REGION, 2019–2026 (USD MILLION) 98
10.2 ASIA PACIFIC 98
FIGURE 27 ASIA PACIFIC: 5G IN HEALTHCARE MARKET SNAPSHOT 99
TABLE 23 APAC: 5G IN HEALTHCARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
TABLE 24 APAC: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 100
TABLE 25 APAC: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 100
TABLE 26 APAC: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 101
10.2.1 CHINA 101
10.2.1.1 China dominates the APAC 5G in healthcare market 101
TABLE 27 CHINA: MACROECONOMIC INDICATORS 102
TABLE 28 CHINA: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 103
TABLE 29 CHINA: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 103
TABLE 30 CHINA: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 103
10.2.2 JAPAN 104
10.2.2.1 Japan has a strong base of technologically advanced healthcare verticals that offer multiple opportunities for the growth of the 5G network 104
TABLE 31 JAPAN: MACROECONOMIC INDICATORS 105
TABLE 32 JAPAN: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 105
TABLE 33 JAPAN: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 105
TABLE 34 JAPAN: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 106
10.2.3 SOUTH KOREA 106
10.2.3.1 Increased spending on geriatric health and coverage for major chronic diseases to support market growth in South Korea 106
TABLE 35 SOUTH KOREA: MACROECONOMIC INDICATORS 107
TABLE 36 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 108
TABLE 37 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 108
TABLE 38 SOUTH KOREA: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 108
10.2.4 AUSTRALIA 109
10.2.4.1 Favorable R&D tax benefits offered in the country to drive market growth 109
TABLE 39 AUSTRALIA: MACROECONOMIC INDICATORS 109
TABLE 40 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 110
TABLE 41 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 110
TABLE 42 AUSTRALIA: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 110
10.2.5 REST OF ASIA PACIFIC 111
TABLE 43 ROAPAC: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 111
TABLE 44 ROAPAC: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 112
TABLE 45 ROAPAC: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 112
10.3 NORTH AMERICA 112
FIGURE 28 NORTH AMERICA: 5G IN HEALTHCARE MARKET SNAPSHOT 114
TABLE 46 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114
TABLE 47 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 115
TABLE 48 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 115
TABLE 49 NORTH AMERICA: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 115
10.3.1 US 116
10.3.1.1 The US dominates the North American 5G in healthcare market 116
TABLE 50 US: MACROECONOMIC INDICATORS 117
TABLE 51 US: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 117
TABLE 52 US: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 117
TABLE 53 US: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION) 118
10.3.2 CANADA 118
10.3.2.1 Deployment of digital services to drive market growth 118
TABLE 54 CANADA: MACROECONOMIC INDICATORS 119
TABLE 55 CANADA: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 119
TABLE 56 CANADA: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 119
TABLE 57 CANADA: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 120
10.4 EUROPE 120
TABLE 58 EUROPE: 5G IN HEALTHCARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 121
TABLE 59 EUROPE: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 121
TABLE 60 EUROPE: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 121
TABLE 61 EUROPE: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 122
10.4.1 GERMANY 122
10.4.1.1 Germany accounted for the largest share of the European 5G in healthcare market in 2020 122
TABLE 62 GERMANY: MACROECONOMIC INDICATORS 123
TABLE 63 GERMANY: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 123
TABLE 64 GERMANY: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 123
TABLE 65 GERMANY: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 124
10.4.2 UK 124
10.4.2.1 Government initiatives favoring the adoption of digitalization to drive market growth 124
TABLE 66 UK: MACROECONOMIC INDICATORS 125
TABLE 67 UK: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 125
TABLE 68 UK: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 126
TABLE 69 UK: 5G IN HEALTHCARE MARKET, BY END USER, 2019–2026 (USD MILLION) 126
10.4.3 REST OF EUROPE 126
TABLE 70 ROE: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 127
TABLE 71 ROE: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 127
TABLE 72 ROE: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 128
10.5 LATIN AMERICA 128
10.5.1 5G IN HEALTHCARE MARKET IN LATIN AMERICA IS IN THE NASCENT PHASE AND IS EXPECTED TO GROW AT A STEADY RATE IN THE FORECAST PERIOD 128
TABLE 73 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 129
TABLE 74 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 129
TABLE 75 LATIN AMERICA: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 129
10.6 MIDDLE EAST & AFRICA 130
10.6.1 RISING DEMAND FOR BETTER TECHNOLOGY-ENABLED MEDICAL DEVICES TO SUPPORT MARKET GROWTH 130
TABLE 76 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 130
TABLE 77 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 131
TABLE 78 MIDDLE EAST & AFRICA: 5G IN HEALTHCARE MARKET, BY END USER,
2019–2026 (USD MILLION) 131

11 COMPETITIVE LANDSCAPE 132
11.1 INTRODUCTION 132
FIGURE 29 KEY DEVELOPMENTS BY MAJOR PLAYERS BETWEEN JANUARY
2018 AND AUGUST 2021 132
11.2 COMPETITIVE BENCHMARKING 133
11.2.1 COMPONENT FOOTPRINT OF COMPANIES 133
11.2.2 REGIONAL FOOTPRINT OF COMPANIES 134
11.3 5G IN HEALTHCARE MARKET: R&D EXPENDITURE 135
FIGURE 30 R&D EXPENDITURE OF KEY PLAYERS IN THE 5G IN HEALTHCARE MARKET (2019 VS. 2020) 135
11.4 REVENUE ANALYSIS OF KEY MARKET PLAYERS 135
FIGURE 31 5G IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY
MARKET PLAYERS (2020) 136
11.5 COMPETITIVE LEADERSHIP MAPPING 136
11.5.1 STARS 136
11.5.2 EMERGING LEADERS 136
11.5.3 PERVASIVE PLAYERS 137
11.5.4 PARTICIPANTS 137
FIGURE 32 COMPETITIVE LEADERSHIP MAPPING: 5G IN HEALTHCARE MARKET, 2020 137
11.6 MARKET RANKING ANALYSIS 138
FIGURE 33 5G IN HEALTHCARE MARKET RANKING ANALYSIS, BY KEY PLAYER, 2020 138
11.7 COMPETITIVE SITUATION AND TRENDS 139
11.7.1 COMPONENT LAUNCHES 139
11.7.2 DEALS 140
11.7.3 OTHER DEVELOPMENTS 141
12 COMPANY PROFILES 142
12.1 KEY PLAYERS 142
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 AT&T 142
TABLE 79 AT&T: BUSINESS OVERVIEW 142
FIGURE 34 AT&T: COMPANY SNAPSHOT (2020) 143
12.1.2 VERIZON 146
TABLE 80 VERIZON: BUSINESS OVERVIEW 146
FIGURE 35 VERIZON: COMPANY SNAPSHOT (2020) 147
12.1.3 ERICSSON 150
TABLE 81 ERICSSON: BUSINESS OVERVIEW 150
FIGURE 36 ERICSSON: COMPANY SNAPSHOT (2020) 151
12.1.4 T-MOBILE 154
TABLE 82 T-MOBILE: BUSINESS OVERVIEW 154
FIGURE 37 T-MOBILE: COMPANY SNAPSHOT (2020) 155
12.1.5 CHINA MOBILE LIMITED 157
TABLE 83 CHINA MOBILE LIMITED: BUSINESS OVERVIEW 157
FIGURE 38 CHINA MOBILE LIMITED: COMPANY SNAPSHOT (2020) 157
12.1.6 CISCO 159
TABLE 84 CISCO: BUSINESS OVERVIEW 159
FIGURE 39 CISCO: COMPANY SNAPSHOT (2020) 160
12.1.7 TELUS 162
TABLE 85 TELUS: BUSINESS OVERVIEW 162
FIGURE 40 TELUS: COMPANY SNAPSHOT (2020) 163
12.1.8 HUAWEI TECHNOLOGIES CO., LTD. 165
TABLE 86 HUAWEI TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW 165
FIGURE 41 HUAWEI TECHNOLOGIES CO., LTD.: COMPANY SNAPSHOT (2020) 166
12.1.9 TELIT 168
TABLE 87 TELIT: BUSINESS OVERVIEW 168
FIGURE 42 TELIT: COMPANY SNAPSHOT (2020) 168
12.1.10 ORANGE S.A. 170
TABLE 88 ORANGE S.A.: BUSINESS OVERVIEW 170
FIGURE 43 ORANGE S.A.: COMPANY SNAPSHOT (2020) 171
12.1.11 TELEFÓNICA 173
TABLE 89 TELEFÓNICA: BUSINESS OVERVIEW 173
FIGURE 44 TELEFÓNICA: COMPANY SNAPSHOT (2020) 174
12.1.12 SK TELECOM CO., LTD. 176
TABLE 90 SK TELECOM CO., LTD.: BUSINESS OVERVIEW 176
FIGURE 45 SK TELEKOM CO., LTD.: COMPANY SNAPSHOT (2020) 177
12.1.13 SAMSUNG 179
TABLE 91 SAMSUNG: BUSINESS OVERVIEW 179
FIGURE 46 SAMSUNG: COMPANY SNAPSHOT (2020) 180
12.1.14 BT GROUP 182
TABLE 92 BT GROUP: BUSINESS OVERVIEW 182
FIGURE 47 BT GROUP: COMPANY SNAPSHOT (2020) 183
12.1.15 DEUTSCHE TELEKOM 185
TABLE 93 DEUTSCHE TELEKOM AG: BUSINESS OVERVIEW 185
FIGURE 48 DEUTSCHE TELEKOM AG: COMPANY SNAPSHOT (2020) 186
12.1.16 VODAFONE 188
TABLE 94 VODAFONE: BUSINESS OVERVIEW 188
FIGURE 49 VODAFONE: COMPANY SNAPSHOT (2020) 189
12.1.17 NOKIA 191
TABLE 95 NOKIA: BUSINESS OVERVIEW 191
FIGURE 50 NOKIA: COMPANY SNAPSHOT (2020) 192
12.1.18 NEC CORPORATION 194
TABLE 96 NEC CORPORATION: BUSINESS OVERVIEW 194
FIGURE 51 NEC CORPORATION: COMPANY SNAPSHOT (2020) 194
12.1.19 QUALCOMM 196
TABLE 97 QUALCOMM: BUSINESS OVERVIEW 196
FIGURE 52 QUALCOMM: COMPANY SNAPSHOT (2020) 197
12.1.20 NTT DOCOMO 198
TABLE 98 NTT DOCOMO: BUSINESS OVERVIEW 198
FIGURE 53 NTT DOCOMO: COMPANY SNAPSHOT (2020) 198
12.2 OTHER PLAYERS 200
12.2.1 SIERRA WIRELESS 200
12.2.2 QUECTEL 201
12.2.3 FIBOCOM 201
12.2.4 SWISSCOM 202
12.2.5 SEQUANS 203
12.2.6 AIRTEL 203
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 204
13.1 DISCUSSION GUIDE 204
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 208
13.3 AVAILABLE CUSTOMIZATIONS 210
13.4 RELATED REPORTS 211
13.5 AUTHOR DETAILS 212


お問合せフォーム

    ※レポートのタイトルは自動で入ります。

    お名前(必須)

    会社名(必須)

    部署名

    メールアドレス(必須)

    電話番号

    当ウェブサイトを知った経由を教えてください。

    お問合せ区分(必須)

    お問合せ内容(必須)

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com